Breakout Stocks –  Corona Virus Stocks –  Top Mining Stocks  – Best Med Stocks


Pressure BioSciences Inc


These shares broke out last month trading above its short term resistance of $4.69 before consolidating to present bargain levels.

We feel that at current levels these shares could again test $4.69 resistance before moving higher  to the next level .

We feel that all serious investors should place these shares on their buy list with a long term target of $5.50 based upon the following :

Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals –

Plans for Accelerating Revenue Growth, and Path to Profitability in 2022 – Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences

South Easton, MA, September 28, 2021 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today announced that the Company has accepted invitations to present at this week’s Benzinga Healthcare and Emerging Growth Small Cap Conferences.

These real-time, interactive investor conferences will feature presentations from multiple up-and-coming, innovative, and exciting small cap companies.

PBI’s President and CEO, Mr. Richard T. Schumacher, will present a corporate overview – including a discussion of its resurgent revenue growth in 2021, the potential impact of the anticipated commercial release of its revolutionary Ultra Shear Technology™ (UST™) platform, its impending acquisition of assets of a global eco-friendly agrochemicals company, andits planned up-list to a U.S. national stock exchange. Mr. Schumacher’s presentation information is below:

Emerging Growth Conference
DATE: Wednesday, September 29, 2021
TIME: 10:30 am EDT
REGISTER (free): To Register for the Emerging Growth Conference,

Benzinga Healthcare Small Cap Conference
DATE: Thursday, September 30, 2021
TIME: 10:30 am EDT
REGISTER (free): To Register for the Benzinga Healthcare Small Cap Conference,

About Pressure BioSciences, Inc. Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and
ultra-high levels to control bio-molecular interactions safely and reproducibly

Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, bio therapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies inthe following areas:

(1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “Baro Fold”technology) to allow entry into the bio-pharma contract services sector, and

(2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies..

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662

For more information about PBI and this press release, please click on the following website link:


Please visit us on Facebook, LinkedIn, and Twitter.


Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,””plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating thesestatements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks,uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.d. Writer is paid $925/mo by company